NCT06157983Active, not recruiting
Evaluation of Cascade Screening for Elevated Lipoprotein(a)
Evaluation of Cascade Screening for Elevated Lipoprotein(a) in Relatives to Patients With Atherosclerotic Coronary Artery Disease
Source: ClinicalTrials.gov · Last updated 8 Jun 2025
Brief summary (registry, in English)
The aim of the current project is to evaluate the penetrance of elevated plasma Lp(a) levels in patients with atherosclerotic coronary artery disease to their first- and second-degree biological relatives based on data from a clinical health care development project.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1950 (estimated)
- First submitted
- 23 Nov 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 16 Jun 2025
- Lead sponsor
- Karolinska Institutet
- Diseases
- Coronary artery disease
- NCT number
- NCT06157983
What you commit to
- Study type: Observational
- Planned participants: 1950
- From 1 Dec 2023 to the primary completion date, 16 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- chronic kidney disease stadium ≥4
Other
- diagnosis of familial hypercholesterolemia
Who the study is looking for
- participation in the clinical health care development project
- established atherosclerotic coronary artery disease
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinska University Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.